The current composition of the NCCR was established to ensure that it becomes visionary and pro-active in driving the development of clinical research in the country.

The committee is made up of member representatives and experts from the Ministry of Health (MOH), various national Universities, the Malaysian Pharmaceutical Society (MPS), the Pharmaceutical Association of Malaysia (PhAMA), the Malaysian Organisation of Pharmaceutical Industries (MOPI), as well as other Non-Governmental Organisations. The composition of the member representatives reflects the on-going “smart-partnerships” amongst the various stake-holders with interests in quality clinical research in Malaysia.

The NCCR committee members include: 

Tan Sri Datuk Seri Dr Hj Mohd. Ismail Merican (Chairman)
Director-General of Health
Ministry of Health, Malaysia

Dr Maimunah A Hamid
Deputy Director General of Health (Research and Technical Support)
Ministry of Health, Malaysia

Professor Dato' Paduka Dr Khalid Yusoff
Dean of  Medical Faculty
Universiti Teknologi Mara, Selangor

Dato' Dr Chang Kian Meng
Chairman of Medical Research & Ethics Committee
Ministry of Health, Malaysia

Dato' Dr. Nor Shahidah Khairullah
Malaysian Liver Foundation, Kuala Lumpur

Dr Lim Teck Onn
Director
Clinical Research Centre, Kuala Lumpur

Dr Shahnaz Murad
Director
Institute for Medical Research, Kuala Lumpur

Professor Dr Abd Rashid Abd Rahman
Vice President (Research and International Development)
Cyberjaya University College of Medical Sciences

Professor Dr V Navaratnam
Centre for Drug Research
Universiti Sains Malaysia, Pulau Pinang

Professor Dr Zahurin Mohamed
Head of Pharmacology Department
Universiti Malaya Medical Centre

Profesor Looi Lai Meng
Pathology Department
Universiti Malaya Medical Faculty

Mr Selvaraja Seerangam
Director
National Pharmaceutical Control Bureau, Selangor

Dr Ramli Abdul Ghani
Director
Traditional & Complementary Medicine Division
Ministry of Health, Malaysia

Dr Zakiah Ismail
Head of Herbal Medicine Research Centre
Institute for Medical Research, Kuala Lumpur

Dr Ho Tze Ming
Institute for Medical Research, Kuala Lumpur

Dr Sarojini Sivanandam
Head of Clinical Trial Unit
Clinical Research Centre, Kuala Lumpur

Dr Kamaruzaman Saleh
Secretary
National Committee for Clinical Research
Ministry of Health, Malaysia

Mr Zaril Harza Zakaria
Secretariat
National Committee for Clinical Research
Ministry of Health, Malaysia

Professor Dr Yeoh Peng Nam
Malaysian Pharmaceutical Society (MPS) Representative

Dr Sharmila Ramanchandran
Pharmaceutical Association of Malaysia (PhAMA) Representative

Dr Akhmal Yusoff
Pharmaceutical Association of Malaysia (PhAMA) Representative

Dr Azizi Ayob
Malaysian Organisation of Pharmaceutical Industries (MOPI) Representative

Ms Zarina Noordin
Malaysian Organisation of Pharmaceutical Industries (MOPI) Representative

Various Sub-committees are formed to facilitate the work and operations of the NCCR. These include:

•	Sub-committee on “Site Visit” for Clinical Research Infrastructure This committee was established to identify the strengths and weaknesses of the present research centres infrastructure, and to take necessary actions in improving them so that clinical research can be carried out in Malaysia
•	Sub-committee for “Guidelines for Application to Conduct Drug-Related Clinical Trials in Malaysia” Guidance for researchers and the pharmaceutical industries who are interested in conducting clinical research in Malaysia
•	Sub-committee for “Good Laboratory Practice” (GLP) This committee was established to develop the Good Laboratory Practice (GLP) Guidelines and organise courses related to it
•	Sub-committee for Bio-Equivalence Studies (BE) The “ASEAN Guidelines for the Conduct of Bioavailability and Bioequivalence Studies” which was prepared by Malaysia based on the "Malaysian Guidelines for the Conduct of Bioavailability and Bioequivalence Studies" was adopted by ASEAN with minor changes during the 8th ACCSQ PPWG Meeting in Bangkok, July 2004
•	Sub-Committee for Clinical Trial Import Licence Guidance for researchers and the pharmaceutical industries who wish to import investigational products which are not registered in Malaysia for clinical research.

 Print Friendly